Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other Non-Current Liabilities: 2010-2025

Historic Other Non-Current Liabilities for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to $25.0 million.

  • Lifecore Biomedical's Other Non-Current Liabilities fell 1.61% to $25.0 million in Q2 2025 from the same period last year, while for May 2025 it was $25.0 million, marking a year-over-year decrease of 1.61%. This contributed to the annual value of $25.0 million for FY2025, which is 1.61% down from last year.
  • As of FY2025, Lifecore Biomedical's Other Non-Current Liabilities stood at $25.0 million, which was down 1.61% from $25.4 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Other Non-Current Liabilities peaked at $64.9 million during FY2023, and registered a low of $190,000 during FY2022.
  • Its 3-year average for Other Non-Current Liabilities is $38.4 million, with a median of $25.4 million in 2024.
  • Per our database at Business Quant, Lifecore Biomedical's Other Non-Current Liabilities crashed by 93.38% in 2022 and then soared by 34,057.89% in 2023.
  • Lifecore Biomedical's Other Non-Current Liabilities (Yearly) stood at $2.9 million in 2021, then slumped by 93.38% to $190,000 in 2022, then skyrocketed by 34,057.89% to $64.9 million in 2023, then slumped by 60.86% to $25.4 million in 2024, then declined by 1.61% to $25.0 million in 2025.